Cargando…

The Impact of Mild Chronic Stress and Maternal Experience in the Fmr1 Mouse Model of Fragile X Syndrome

Fragile X syndrome (FXS) is a pervasive developmental disorder and the most common monogenic cause of autism spectrum disorder (ASD). Female heterozygous (HET) carriers play a major role in the transmission of the pathology and present several FXS- and ASD-like behavioral alterations. Despite their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subashi, Enejda, Lemaire, Valerie, Petroni, Valeria, Pietropaolo, Susanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380347/ https://www.ncbi.nlm.nih.gov/pubmed/37511156 http://dx.doi.org/10.3390/ijms241411398

Ejemplares similares

Long-term behavioral effects of prenatal stress in the Fmr1-knock-out mouse model for fragile X syndrome
por: Petroni, Valeria, et al.
Publicado: (2022)

Autistic-like behavioral effects of prenatal stress in juvenile Fmr1 mice: the relevance of sex differences and gene–environment interactions
por: Petroni, Valeria, et al.
Publicado: (2022)

Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
por: Premoli, Marika, et al.
Publicado: (2023)

Hyperacusis in the Adult Fmr1-KO Mouse Model of Fragile X Syndrome: The Therapeutic Relevance of Cochlear Alterations and BKCa Channels
por: Ferraguto, Celeste, et al.
Publicado: (2023)

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule
por: Hébert, Betty, et al.
Publicado: (2014)

Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome
por: Mor-Shaked, Hagar, et al.
Publicado: (2018)

Impaired hippocampal representation of place in the Fmr1-knockout mouse model of fragile X syndrome
por: Arbab, Tara, et al.
Publicado: (2018)

Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model
por: Naviaux, Jane C, et al.
Publicado: (2015)

NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome
por: Kurosaki, Tatsuaki, et al.
Publicado: (2021)

Fragile X Syndrome Caused by Maternal Somatic Mosaicism of FMR1 Gene: Case Report and Literature Review
por: Gómez-Rodríguez, Maria Jose, et al.
Publicado: (2022)

Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI)
por: Alvarez-Mora, Maria Isabel, et al.
Publicado: (2022)

Spontaneous Coronary Artery Dissection in Females With the Fragile X FMR1 Premutation
por: McKenzie, Forrest J., et al.
Publicado: (2020)

Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice
por: Kim, Yujeong, et al.
Publicado: (2022)

Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders
por: Usdin, Karen, et al.
Publicado: (2015)

Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells
por: Haenfler, Jill M., et al.
Publicado: (2018)

DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome
por: Nobile, Veronica, et al.
Publicado: (2021)

Fmr1-Deficiency Impacts Body Composition, Skeleton, and Bone Microstructure in a Mouse Model of Fragile X Syndrome
por: Leboucher, Antoine, et al.
Publicado: (2019)

Health and reproductive experiences of women with an FMR1 premutation with and without fragile X premature ovarian insufficiency
por: Wheeler, Anne C., et al.
Publicado: (2014)

Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field
por: Hunsaker, Michael R.
Publicado: (2013)

Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding
por: Napoli, Eleonora, et al.
Publicado: (2016)

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
por: Chonchaiya, Weerasak, et al.
Publicado: (2010)

Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders
por: Usdin, Karen, et al.
Publicado: (2014)

Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome†
por: Tabolacci, Elisabetta, et al.
Publicado: (2016)

FMR1 premutation with Prader–Willi phenotype and fragile X‐associated tremor/ataxia syndrome
por: Martínez‐Cerdeño, Verónica, et al.
Publicado: (2017)

Fragile X Syndrome in a Female With Homozygous Full-Mutation Alleles of the FMR1 Gene
por: Vafaeie, Farzane, et al.
Publicado: (2021)

Cell-Type Specific Channelopathies in the Prefrontal Cortex of the fmr1-/y Mouse Model of Fragile X Syndrome(1,2,3)
por: Kalmbach, Brian E., et al.
Publicado: (2015)

Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits
por: Jiang, Yiru, et al.
Publicado: (2022)

Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome
por: Stöger, Reinhard, et al.
Publicado: (2011)

Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus
por: Alisch, Reid S, et al.
Publicado: (2013)

FMR1 Epigenetic Silencing Commonly Occurs in Undifferentiated Fragile X-Affected Embryonic Stem Cells
por: Avitzour, Michal, et al.
Publicado: (2014)

Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines
por: Dolskiy, Alexander A., et al.
Publicado: (2017)

A microRNA cluster in the Fragile‐X region expressed during spermatogenesis targets FMR1
por: Ramaiah, Madhuvanthi, et al.
Publicado: (2018)

Pharmacological Reactivation of the Silenced FMR1 Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
por: Kumari, Daman, et al.
Publicado: (2019)

Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome
por: Kozono, Naoki, et al.
Publicado: (2020)

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
por: Thomas, Scott, et al.
Publicado: (2021)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022)

Defining the 3′Epigenetic Boundary of the FMR1 Promoter and Its Loss in Individuals with Fragile X Syndrome
por: Godler, David E., et al.
Publicado: (2023)

Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome–Like Phenotype
por: Collins, Stephen C., et al.
Publicado: (2010)

Development of Genetic Testing for Fragile X Syndrome and Associated Disorders, and Estimates of the Prevalence of FMR1 Expansion Mutations
por: Macpherson, James N., et al.
Publicado: (2016)

Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome
por: Xie, Nina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pb5rvbmssapk3v24f2s26k7r0f